Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

53.50
Delayed Data
As of Jul 29
 -1.29 / -2.35%
Today’s Change
48.01
Today|||52-Week Range
71.78
-18.49%
Year-to-Date
Mylan's Weakness Shouldn't Last, So Buy Now
Jul 29 / TheStreet.com - Paid Partner Content
An Investing Overview of the Multiple Sclerosis Market
Jul 26 / MotleyFool.com - Paid Partner Content
Allergan Cures Its Ailing Chart
Jul 28 / TheStreet.com - Paid Partner Content
Jim Cramer -- I Agree With the Analysts on Gap, Allergan
Jul 25 / TheStreet.com - Paid Partner Content
Teva (TEVA) Stock Up, Allergen Deal Receives Clearance
Jul 28 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close54.79
Today’s open54.79
Day’s range53.33 - 54.83
Volume6,096,523
Average volume (3 months)5,959,781
Market cap$50.4B
Dividend yield2.54%
Data as of 4:00pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-48.62%
Earnings growth (this year)-2.61%
Earnings growth (next 5 years)+6.45%
Revenue growth (last year)-3.22%
P/E ratio27.9
Price/Sales2.89
Price/Book1.89

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd-1.16-4.23%
OASMOasmia Pharmaceutica...+0.02+0.63%
VBLTVascular Biogenics L...0.000.00%
DNAIProNAi Therapeutics ...-0.01-0.51%
Data as of 3:59pm ET, 07/29/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)$1.19
Annual revenue (last year)$19.6B
Annual profit (last year)$1.6B
Net profit margin8.09%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Erez Vigodman
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Tel Aviv

Forecasts

Partner Offers

Search for Jobs